Nirvair Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
About Nirvair Lifesciences
Nirvair Lifesciences Private Limited (NLPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 July 2018 (Six years and six months 28 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.50 M.
Kamaldeep Singh, Gaurav Garg, Kapil Jaggi, and Two other members serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2018PTC336769
-
Company No.
336769
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Jul 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Nirvair Lifesciences?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamaldeep Singh
|
Director | 19-Jul-2018 | Current |
|
Gaurav Garg
|
Director | 19-Jul-2018 | Current |
|
Kapil Jaggi
|
Director | 16-Oct-2018 | Current |
|
Kapil Rakha
|
Director | 16-Oct-2018 | Current |
|
Lalit Chawla
|
Director | 16-Oct-2018 | Current |
Financial Performance of Nirvair Lifesciences.
Enhance accessibility to Nirvair Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nirvair Lifesciences?
Unlock access to Nirvair Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2019 | Others | ₹0.50 M | Open |
How Many Employees Work at Nirvair Lifesciences?
Unlock and access historical data on people associated with Nirvair Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirvair Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirvair Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.